top of page

Fast & Cool Speaker

CYBERIA_1.png
NeuroRX
More than 500 people with bipolar disease die each day from suicidal crisis across the OECD countries. NeuroRx has demonstrated human proof of concept for a first-in-class, rapid-onset, sustained therapy for this condition, which currently has no approved treatment.
Sold to

BCAEA

CYBERIA_1.png

2015

Jonathan Javitt
CEO
Jonathan C. Javitt, M.D., M.P.H. is an international expert in Pharmaceutical and MedDevice development, and Health IT. He has played a leading role in six startups with successful public exits and been appointed to leadership positions by 3 US Presidents.
bottom of page